The following table details the components of our other assets at the dates indicated ($ in thousands):


	June 30, 2026		December 31, 2025
Interest receivable	$	—	$	70,833
Collateral deposited under derivative agreements		—		27,440
Loan proceeds held by servicer(1)		—		4,151
Equity method investment(2)		24,970		23,764
Other(3)		14,884		17,791
Total	$	39,854	$	143,979

(1)

Includes loan principal, interest, and other fees held by our third-party servicers as of the balance sheet date and remitted during subsequent remittance cycle.

(2)

Relates to the Massachusetts Healthcare JV (as defined below) with other Apollo-managed entities that owns two hospitals in Massachusetts. Refer to "Massachusetts Healthcare" below for additional information.

(3)

Includes $12.6 million and $16.1 million of other assets from Real Estate Owned, Held for Investment as of June 30, 2026 and December 31, 2025, respectively. Refer to "Note 5 – Real Estate Owned" for additional information.

In 2022, we and other Apollo-managed entities ("Apollo Co-Lenders") co-originated a first mortgage loan ("Massachusetts Healthcare Loan") secured by eight hospitals in Massachusetts. During the third quarter of 2024, we and the Apollo Co-Lenders, through a joint venture ("Massachusetts Healthcare JV"), acquired title to one of the eight hospitals (St. Elizabeth's Medical Center) that previously secured the Massachusetts Healthcare Loan. During the same period, the hospital was taken by eminent domain by the Commonwealth of Massachusetts (the "Commonwealth"). Refer to "Note 16 - Commitments and Contingencies" for additional information regarding the Commonwealth's taking of the hospital and the associated lawsuit against the Commonwealth.

Additionally in the third quarter of 2024, guarantors made a guaranty payment on the Massachusetts Healthcare Loan, and the Borrowers transferred the deeds of the remaining seven hospitals into escrow, thereby releasing the borrowers from their obligation under the loan agreement. As a result, during the third quarter of 2024, we recorded a $127.5 million realized loss on investments in relation to the Massachusetts Healthcare Loan. During the fourth quarter of 2024, five of the seven hospitals were sold to third parties and the proceeds were allocated among us and other Apollo Co-Lenders based on our pro-rata interests in the Massachusetts Healthcare Loan. During the first quarter of 2025, the Massachusetts Healthcare JV took title of the two unsold hospitals.

For the three and six months ended June 30, 2026, we contributed $0.8 million and $1.7 million, respectively, to the Massachusetts Healthcare JV. Additionally, our allocation of loss from the Massachusetts Healthcare JV for the three and six months ended June 30, 2026 was $0.2 million and $0.5 million, recorded within loss from equity method investment, net on our condensed consolidated statement of operations. For the three and six months ended June 30, 2025, we contributed $0.9 million and $4.2 million, respectively, to the Massachusetts Healthcare JV. Additionally, our allocation of losses from the Massachusetts Healthcare JV for the three and six months ended June 30, 2025 was $0.7 million and $1.4 million, respectively, recorded within

other income, net on our condensed consolidated statement of operations. Refer to "Note 16 – Commitments and Contingencies" for additional information.

As of June 30, 2026 and December 31, 2025, our equity method investment in the Massachusetts Healthcare JV was $25.0 million and $23.8 million, recorded in other assets on our condensed consolidated balance sheet.